FDA Inspection 978125 — APCER Life Sciences, Inc.
The FDA completed an inspection of APCER Life Sciences, Inc. on Jun 21, 2016 in Princeton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 21, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Princeton, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)